BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Agendia BV 

Slotervaart Medical Centre, 9D
Louwesweg 6
Amsterdam    1066 EC  The Netherlands
Phone: 31-20-512-9161 Fax: 31-20-512-9162


SEARCH JOBS




Industry
Services
Healthcare






 Company News
Agendia BV Appoints Jan Egberts, M.D., As CEO 10/2/2014 6:06:47 AM
Agendia BV Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment 9/16/2014 8:57:23 AM
Agendia BV Test For Molecular Subtyping Of Breast Cancer Is A Better Guide To Pre-Surgical Treatment, Study Finds 9/15/2014 10:45:28 AM
Agendia BV Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment 9/2/2014 11:05:49 AM
Agendia BV Co-Founder And CSO Develops Method To Identify Women Who Will Benefit From Tamoxifen Therapy For Breast Cancer 7/31/2014 10:59:07 AM
Agendia BV And CBLpath Announce Agreement To Assist Physicians In Diagnostic Assessment Of Breast Cancer 7/16/2014 8:39:05 AM
Agendia BV Release: Value Of Breast Cancer Molecular Subtyping Documented By Independent Study Comparing Genomic Tests At American Society of Clinical Oncology 2014 Meeting 6/10/2014 9:57:44 AM
Molecular Subtyping With Agendia BV Tests Can Provide Better Guidance For Breast Cancer Treatment, New Research Reports 5/7/2014 10:18:28 AM
Agendia BV Announces New Agreement With Daiichi Sankyo, Inc. (4568.t) To Support Oncology Drug Development 4/24/2014 7:58:18 AM
Agendia BV Co-Founder Will Receive EU Prize For Women Innovators 3/7/2014 8:38:18 AM
123456789